The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Self-citationCancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 4×
“We analyzed a cohort of 959 colorectal tumors from patients presenting with diverse tumor node metastasis (TNM) grading and from all colorectal locations (from right colon to rectum) with up to 15 years of clinical follow-up for the presence or absence of VELIPI (Pagès et al., 2005).”
MethodResultInfluentialSelf-citationImmunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324 · cited 1×
“Therefore, it is time to propose the immune reaction as a seventh hallmark of cancer, as proposed by Zitvogel et al. (2006), and to integrate the analysis and quantification of immune infiltrates as a routine prognostic factor.”
BackgroundModel Predicting Survival in Stage I Melanoma Based on Tumor Progression
Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247
Ghiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., & Chauffert, B. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0225-8 · Cited by 1,241
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Clemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Self-citationCOLEY, W. B. (1893) · The American Journal of the Medical Sciences · doi:10.1097/00000441-189305000-00001 · Cited by 995
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
COLEY, W. B. (1991) · PubMed · Cited by 965
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Pagès, F., Kirilovsky, A., Mlecnik, B., Asslaber, M., Tosolini, M., Bindea, G., Lagorce, C., Wind, P., Marliot, F., Bruneval, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6147 · Cited by 954
Self-citationCTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Hiraoka, N., Onozato, K., Kosuge, T., & Hirohashi, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0369 · Cited by 831
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., Woodland, D. L., Lund, F. E., & Randall, T. D. (2004) · Nature Medicine · doi:10.1038/nm1091 · Cited by 821
A fresh look at tumor immunosurveillance and immunotherapy
Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001) · Nature Immunology · doi:10.1038/86297 · Cited by 745
The PD-1–PD-L pathway in immunological tolerance
Okazaki, T., & Honjo, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.001 · Cited by 721
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H., & Ohtani, H. (2001) · PubMed · Cited by 639
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Cancer risk after renal transplantation in the nordic countries, 1964–1986
Birkeland, S. A., Storm, H. H., Lamm, L. U., Barlow, L., Blohmé, I., Forsberg, B., Eklund, B., Fjeldborg, O., Friedberg, M., Frödin, L., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600209 · Cited by 613
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 598
Self-citationHumby, F., Bombardieri, M., Manzo, A., Kelly, S., Blades, M. C., Kirkham, B., Spencer, J., & Pitzalis, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.0060001 · Cited by 537
Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611618104 · Cited by 526
Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H., & Hori, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811556106 · Cited by 523
TNM residual tumor classification revisited
Wittekind, C., Compton, C. C., Greene, F. L., & Sobin, L. H. (2002) · Cancer · doi:10.1002/cncr.10492 · Cited by 507
Carreras, J., Lopez-Guillermo, A., Fox, B. C., Colomo, L., Martinez, A., Roncador, G., Montserrat, E., Campo, E., & Banham, A. H. (2006) · Blood · doi:10.1182/blood-2006-04-018218 · Cited by 503
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
Schumacher, K., Haensch, W., Röefzaad, C., & Schlag, P. M. (2001) · PubMed · Cited by 503
Hohenberger, P., & Gretschel, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13975-x · Cited by 497
Rangel-Moreno, J., Hartson, L., Navarro, C., Gaxiola, M., Selman, M., & Randall, T. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28756 · Cited by 493
Hiraoka, K., Miyamoto, M., Cho, Y., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., Ohbuchi, T., Kondo, S., & Katoh, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602934 · Cited by 481
The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel Perspective
Galon, J., Fridman, W.-H., & Pagès, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4806 · Cited by 447
Self-citationTumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression
Kim, R., Emi, M., Tanabe, K., & Arihiro, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4128 · Cited by 445
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Tzankov, A., Meier, C., Hirschmann, P., Went, P., Pileri, S. A., & Dirnhofer, S. (2008) · Haematologica · doi:10.3324/haematol.11702 · Cited by 412
Leffers, N., Gooden, M. J. M., de Jong, R. A., Hoogeboom, B.-N., ten Hoor, K. A., Hollema, H., Boezen, H. M., van der Zee, A. G. J., Daemen, T., & Nijman, H. W. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0583-5 · Cited by 402
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
Ropponen, K. M., Eskelinen, M. J., Lipponen, P. K., Alhava, E., & Kosma, V.-M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199707)182:3<318::aid-path862>3.0.co;2-6 · Cited by 398
Schwitalle, Y., Kloor, M., Eiermann, S., Linnebacher, M., Kienle, P., Knaebel, H. P., Tariverdian, M., Benner, A., & von Knebel Doeberitz, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.015 · Cited by 387
Kawai, O., Ishii, G., Kubota, K., Murata, Y., Naito, Y., Mizuno, T., Aokage, K., Saijo, N., Nishiwaki, Y., Gemma, A., et al. (2008) · Cancer · doi:10.1002/cncr.23712 · Cited by 384
Immune-mediated dormancy: an equilibrium with cancer
Teng, M. W. L., Swann, J. B., Koebel, C. M., Schreiber, R. D., & Smyth, M. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107774 · Cited by 359
Lymphocytic infiltration and survival in rectal cancer.
Jass, J. R. (1986) · Journal of Clinical Pathology · doi:10.1136/jcp.39.6.585 · Cited by 356
Hoffmann, P., Boeld, T. J., Eder, R., Huehn, J., Floess, S., Wieczorek, G., Olek, S., Dietmaier, W., Andreesen, R., & Edinger, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838904 · Cited by 354
History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
Herr, H. W., & Morales, A. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.08.122 · Cited by 353
Immunogenic cancer cell death: a key-lock paradigm
Tesniere, A., Apetoh, L., Ghiringhelli, F., Joza, N., Panaretakis, T., Kepp, O., Schlemmer, F., Zitvogel, L., & Kroemer, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.007 · Cited by 307
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
Camus, M., Tosolini, M., Mlecnik, B., Pagès, F., Kirilovsky, A., Berger, A., Costes, A., Bindea, G., Charoentong, P., Bruneval, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2654 · Cited by 306
Self-citationCrohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator.
Graham, D. M., & Appelman, H. D. (1990) · PubMed · Cited by 283
Cho, Y., Miyamoto, M., Kato, K., Fukunaga, A., Shichinohe, T., Kawarada, Y., Hida, Y., Oshikiri, T., Kurokawa, T., Suzuoki, M., et al. (2003) · PubMed · Cited by 278
Ectopic lymphoid tissues and local immunity
Carragher, D. M., Rangel-Moreno, J., & Randall, T. D. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.12.004 · Cited by 274
Helicobacter and gastric MALT lymphoma
Stolte, M., Bayerdörffer, E., Morgner, A., Alpen, B., Wündisch, T., Thiede, C., & Neubauer, A. (2002) · Gut · doi:10.1136/gut.50.suppl_3.iii19 · Cited by 265
Identification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissue
Chaput, N., Louafi, S., Bardier, A., Charlotte, F., Vaillant, J.-C., Ménégaux, F., Rosenzwajg, M., Lemoine, F., Klatzmann, D., & Taieb, J. (2009) · Gut · doi:10.1136/gut.2008.158824 · Cited by 264
Persistence and Responsiveness of Immunologic Memory in the Absence of Secondary Lymphoid Organs
Moyron-Quiroz, J. E., Rangel-Moreno, J., Hartson, L., Kusser, K., Tighe, M. P., Klonowski, K. D., Lefrançois, L., Cauley, L. S., Harmsen, A. G., Lund, F. E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.022 · Cited by 261
Vesalainen, S., Lipponen, P., Talja, M., & Syrjänen, K. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)e0159-2 · Cited by 254
Diederichsen, A. C. P., v. B. Hjelmborg, J., Christensen, P. B., Zeuthen, J., & Fenger, C. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0388-5 · Cited by 237
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue
Nielsen, H. J., Hansen, U., Christensen, I. J., Reimert, C. M., Br�nner, N., Moesgaard, F., & The RANX05 Study Group (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199912)189:4<487::aid-path484>3.0.co;2-i · Cited by 233
Tschernig, T., & Pabst, R. (2000) · Pathobiology · doi:10.1159/000028109 · Cited by 228
PRALL, F. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.01.022 · Cited by 226
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., et al. (2008) · Gut · doi:10.1136/gut.2007.123794 · Cited by 214
From dukes through jass: Pathological prognostic indicators in rectal cancer
Harrison, J. C., Dean, P. J., El-zeky, F., & Vander Zwaag, R. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90122-8 · Cited by 200
Halvorsen, T. B., & Seim, E. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.2.162 · Cited by 187
Lymphoid infiltration and prognosis in colorectal carcinoma
Svennevig, J. L., Lunde, O. C., Holter, J. C., & Bjørgsvik, D. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.60 · Cited by 185
Marrogi, A. J., Munshi, A., Merogi, A. J., Ohadike, Y., El-Habashi, A., Marrogi, O. L., & Freeman, S. M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971021)74:5<492::aid-ijc3>3.0.co;2-z · Cited by 183
Reichert, T. E., Scheuer, C., Day, R., Wagner, W., & Whiteside, T. L. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2136::aid-cncr1242>3.0.co;2-q · Cited by 162
Tefany, F. J., Barnetson, R. S., Halliday, G. M., McCarthy, S. W., & McCarthy, W. H. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12479662 · Cited by 159
B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy
Thaunat, O., Patey, N., Gautreau, C., Lechaton, S., Frémeaux‐Bacchi, V., Dieu‐Nosjean, M., Cassuto, É., Legendre, C. M., Delahousse, M., Lang, P., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e3181735723 · Cited by 148
Self-citationBronchus‐associated lymphoid tissue (BALT) in human fetal and infant lung
Gould, S. J., & Isaacson, P. G. (1993) · The Journal of Pathology · doi:10.1002/path.1711690209 · Cited by 138
Immunology and immunotherapy of colorectal cancer
Dalerba, P. D., Maccalli, C., Casati, C., Castelli, C., & Parmiani, G. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00159-2 · Cited by 133
Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas
Bicknell, D., Kaklamanis, L., Hampson, R., Bodmer, W. F., & Karran, P. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70795-1 · Cited by 132
Michel, S., Benner, A., Tariverdian, M., Wentzensen, N., Hoefler, P., Pommerencke, T., Grabe, N., Doeberitz, M. V. K., & Kloor, M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604756 · Cited by 131
Kärjä, V. J., Aaltomaa, S. H., Lipponen, P., Isotalo, T., Talja, M. T., & Mokka, R. (2005) · PubMed · Cited by 124
The essential role of the in situ immune reaction in human colorectal cancer
Pagès, F., Galon, J., & Fridman, W. H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107773 · Cited by 122
Self-citationMackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S., & Hercend, T. (1993) · PubMed · Cited by 118
Badoual, C., Bouchaud, G., Agueznay, N. E. H., Mortier, E., Hans, S., Gey, A., Fernani, F., Peyrard, S., Laurent‐Puig, P., Bruneval, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6842 · Cited by 106
Self-citationHalama, N., Michel, S., Kloor, M., Zoernig, I., Pommerencke, T., Doeberitz, M. V. K., Schirmacher, P., Weitz, J., Grabe, N., & Jäger, D. (2009) · PubMed · Cited by 84
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
Richardsen, E. H., Uglehus, R. D., Due, J., Busch, C., & Busund, L.-T. R. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03058.x · Cited by 82
Gause, A., Gundlach, K., Zdichavsky, M., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251010 · Cited by 60
Survival and the immune response in patients with carcinoma of the colorectum.
House, A. K., & Watt, A. G. (1979) · Gut · doi:10.1136/gut.20.10.868 · Cited by 52
Ito, N., Suzuki, Y., Taniguchi, Y., Ishiguro, K., Nakamura, H., & Ohgi, S. (2005) · PubMed · Cited by 51
Revisiting the Prognostic Value of Regulatory T Cells in Patients With Cancer
Badoual, C., Hans, S., Fridman, W. H., Brasnu, D. F., Erdman, S. E., & Tartour, É. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0680 · Cited by 48
Self-citationClinical significance of poor CD3 response in head and neck cancer.
Shibuya, T. Y., Nugyen, N., McLaren, C. E., Li, K. T., Wei, W. Z., Kim, S. H., Yoo, G. H., Rogowski, A. S., Ensley, J. F., & Sakr, W. (2002) · PubMed · Cited by 46
Generation of experimental allergic airways inflammation in the absence of draining lymph nodes
Gajewska, B., Álvarez, D., Vidric, M., Goncharova, S. I., Stämpfli, M. R., Coyle, A. J., Gutierrez-Ramos, J.-C., & Jordana, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12627 · Cited by 39
Touitou, V., Daussy, C., Bodaghi, B., Camelo, S., de Kozak, Y., LeHoang, P., Naud, M., Varin, A., Thillaye-Goldenberg, B., Merle‐Béral, H., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0008 · Cited by 37
Self-citationBaier, P., Wimmenauer, S., Hirsch, T., von Specht, B. U., von Kleist, S., Keller, H., & Farthmann, E. H. (1998) · Tumor Biology · doi:10.1159/000030008 · Cited by 31
Peri- and intratumoral T and B lymphocytic infiltration in breast cancer.
Menegaz, R. A., Michelin, M. A., Etchebehere, R. M., Pc, F., & Murta, E. F. C. (2008) · PubMed · Cited by 28
Tesar, B. M., Chalasani, G., Diggs, L., Baddoura, F. K., Lakkis, F. G., & Goldstein, D. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4377 · Cited by 22
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Self-citationMonoclonal antibodies: versatile platforms for cancer immunotherapy
Weiner, L. M., Surana, R., & Wang, S. (2010) · Nature Reviews Immunology · doi:10.1038/nri2744 · Cited by 1,283
Systematic pan-cancer analysis of tumour purity
Aran, D., Sirota, M., & Butte, A. J. (2015) · Nature Communications · doi:10.1038/ncomms9971 · Cited by 1,216
Metadata
- Authors
- Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H.
- Venue
- Oncogene
- Published
- 2009-11-30
- Volume
- 29
- Issue
- 8
- Pages
- 1093-1102
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2150633526
- Cited by
- 1,087
- References
- 99
- FWCI
- 25.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.